These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2957897)
1. Inhibition of prostaglandin biosynthesis by etodolac. I. Selective activities in arthritis. Neuman RG; Wilson BD; Barkley M; Kimball ES; Weichman BM; Wood DD Agents Actions; 1987 Jun; 21(1-2):160-6. PubMed ID: 2957897 [TBL] [Abstract][Full Text] [Related]
2. Etodolac: effect on prostaglandin concentrations in gastric mucosa of rats. Lee D; Dvornik D Life Sci; 1985 Mar; 36(12):1157-62. PubMed ID: 3157036 [TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats. Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837 [TBL] [Abstract][Full Text] [Related]
4. Temporal relationships of the anti-inflammatory effect of etodolac in the adjuvant arthritic rat. Lee DK; Chau TT; Weichman BM; Wooley PH Proc Soc Exp Biol Med; 1988 Mar; 187(3):273-7. PubMed ID: 2964641 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of the new non-steroidal anti-inflammatory agent etodolac. Inoue K; Fujisawa H; Sasaki Y; Nishimura T; Nishimura I; Inoue Y; Yokota M; Masuda T; Ueda F; Shibata Y Arzneimittelforschung; 1991 Mar; 41(3):228-35. PubMed ID: 1651085 [TBL] [Abstract][Full Text] [Related]
7. Etodolac preserves cartilage-specific phenotype in human chondrocytes: effects on type II collagen synthesis and associated mRNA levels. Goldring MB; Sohbat E; Elwell JM; Chang JY Eur J Rheumatol Inflamm; 1990; 10(1):10-21. PubMed ID: 2146129 [TBL] [Abstract][Full Text] [Related]
8. Effect of etodolac, a new nonsteroidal anti-inflammatory drug, in MRL/lpr mice with articular lesions. Yoshida-Suzuka H; Nakamura Y; Shibata Y; Kimura K Agents Actions; 1991 Jul; 33(3-4):310-3. PubMed ID: 1835269 [TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effects of etodolac: comparison with other non-steroidal anti-inflammatory drugs. Inoue K; Fujisawa H; Motonaga A; Inoue Y; Kyoi T; Ueda F; Kimura K Biol Pharm Bull; 1994 Dec; 17(12):1577-83. PubMed ID: 7735198 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandins in inflammatory bone pathology: mechanism and therapeutic benefit of etodolac. Hayward MA; Howard GA; Neuman RG; Wood DD; Weichman BM; Van Sickle DC Agents Actions; 1989 Mar; 26(3-4):310-8. PubMed ID: 2525314 [TBL] [Abstract][Full Text] [Related]
11. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis. Taha AS; McLaughlin S; Holland PJ; Kelly RW; Sturrock RD; Russell RI Ann Rheum Dis; 1990 Jun; 49(6):354-8. PubMed ID: 2143369 [TBL] [Abstract][Full Text] [Related]
12. Histopathologic evaluation of the effects of etodolac in established adjuvant arthritis in rats: evidence for reversal of joint damage. Weichman BM; Chau TT; Rona G Arthritis Rheum; 1987 Apr; 30(4):466-70. PubMed ID: 2953342 [TBL] [Abstract][Full Text] [Related]
13. Comparative effects of long term treatment with etodolac, naproxen and ibuprofen on articular and bone changes associated with adjuvant arthritis in rats. Martel RR; Klicius J; Metcalf G; Rona GA Agents Actions; 1984 Oct; 15(3-4):403-12. PubMed ID: 6240930 [TBL] [Abstract][Full Text] [Related]
14. Etodolac, a novel antiinflammatory agent. The syntheses and biological evaluation of its metabolites. Humber LG; Ferdinandi E; Demerson CA; Ahmed S; Shah U; Mobilio D; Sabatucci J; De Lange B; Labbadia F; Hughes P J Med Chem; 1988 Sep; 31(9):1712-9. PubMed ID: 2970548 [TBL] [Abstract][Full Text] [Related]
15. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894 [TBL] [Abstract][Full Text] [Related]
16. Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formation. Inoue K; Motonaga A; Dainaka J; Nishimura T; Hashii H; Yamate K; Ueda F; Kimura K Prostaglandins Leukot Essent Fatty Acids; 1994 Dec; 51(6):457-62. PubMed ID: 7708812 [TBL] [Abstract][Full Text] [Related]
17. Effect of etodolac on articular and bone pathology associated with adjuvant arthritis in rats: a comparison with aspirin and naproxen. Martel RR; Klicius J; Metcalf G Agents Actions; 1984 Feb; 14(2):257-64. PubMed ID: 6231845 [TBL] [Abstract][Full Text] [Related]
18. Effects of etodolac on human chondrocytes cultivated in three dimensional culture. Henrotin Y; Bassleer C; Reginster JY; Franchimont P Clin Rheumatol; 1989 Mar; 8 Suppl 1():36-42. PubMed ID: 2545406 [TBL] [Abstract][Full Text] [Related]
19. Comparison in rats of the anti-inflammatory and gastric irritant effects of etodolac with several clinically effective anti-inflammatory drugs. Martel RR; Klicius J Agents Actions; 1982 Jul; 12(3):295-7. PubMed ID: 6215841 [TBL] [Abstract][Full Text] [Related]
20. Theoretical mechanism for the gastrointestinal safety of etodolac: selective sparing of cytoprotective prostaglandins. Dvornik D; Lee DK Clin Rheumatol; 1989 Mar; 8 Suppl 1():16-24. PubMed ID: 2525980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]